HealthEquity (NASDAQ:HQY) Stock: Insider Sunil Rajasekar Sells 108 Shares

HealthEquity, Inc. (NASDAQ:HQY) EVP Sunil Rajasekar sold 108 shares of the company’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $105.60, for a total value of $11,404.80. Following the sale, the executive vice president owned 53,297 shares of the company’s stock, valued at $5,628,163.20. This trade represents a 0.20% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Sunil Rajasekar also recently made the following trade(s):

• On Thursday, October 15th, Sunil Rajasekar purchased 108 shares of HealthEquity stock. The stock was bought at an average cost of $90.33 per share, with a total value of $9,755.64.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $96.60 on Wednesday. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47. The stock’s fifty day simple moving average is $95.62 and its two-hundred day simple moving average is $91.63. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $107.62. The stock has a market cap of $7.99 billion, a PE ratio of 34.87, a price-to-earnings-growth ratio of 1.47 and a beta of 0.24.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.05. The firm had revenue of $350.73 million during the quarter, compared to analyst estimates of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The company’s revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, analysts forecast that HealthEquity, Inc. will post 3.93 EPS for the current fiscal year.

Analysts Set New Price Targets

HQY has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft boosted their price target on shares of HealthEquity from $135.00 to $142.00 and gave the stock a “buy” rating in a report on Monday, August 31st. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday, October 10th. Raymond James Financial reiterated a “strong-buy” rating on shares of HealthEquity in a research note on Thursday, September 3rd. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a research report on Friday, August 28th. Finally, BTIG Research restated a “buy” rating and issued a $115.00 target price on shares of HealthEquity in a research note on Friday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and a consensus price target of $112.20.

Institutional Investors Weigh In On HealthEquity

Hedge funds have recently made changes to their positions in the business. BlackRock Inc. bought a new position in HealthEquity during the second quarter valued at $1,018,621,000. Wasatch Advisors LP increased its position in HealthEquity by 10.5% in the second quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock worth $719,014,000 after buying an additional 757,801 shares during the last quarter. William Blair Investment Management LLC purchased a new stake in HealthEquity in the second quarter worth $160,158,000. Dimensional Fund Advisors LP raised its stake in shares of HealthEquity by 2.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,627,039 shares of the company’s stock valued at $135,957,000 after buying an additional 45,287 shares during the period. Finally, Bank of America Corp DE bought a new stake in shares of HealthEquity in the second quarter valued at $103,573,000. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.